Prognostic Value of MMP-2, -9 and TIMP-1,-2 Immunoreactive Protein at the Invasive Front in Advanced Head and Neck Squamous Cell Carcinomas
- 1 January 2002
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 198 (8) , 509-515
- https://doi.org/10.1078/s0344-0338(04)70292-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinomaPathology and Oncology Research, 1999
- Trends in mortality from cancer in the European Union, 1955–94The Lancet, 1999
- MMP-2 and TIMP-2 Expression Correlates with Poor Prognosis in Cervical Carcinoma—A Clinicopathologic Study Using Immunohistochemistry and mRNA in Situ HybridizationGynecologic Oncology, 1999
- Matrix metalloproteinases and metastasisCancer Chemotherapy and Pharmacology, 1999
- Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer.Clinical & Experimental Metastasis, 1999
- Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neckHead & Neck, 1999
- Matrix metalloproteinase inhibitorsBreast Cancer Research and Treatment, 1998
- Collagenase‐3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynxThe Journal of Pathology, 1998
- Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic valueVirchows Archiv, 1995
- Cytokine Regulation of Gelatinase Production by Head and Neck Squamous Cell Carcinoma: The Role of Tumor Necrosis Factor-AlphaAnnals of Otology, Rhinology & Laryngology, 1995